Baker Avenue Asset Management, LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1432529 SAN FRANCISCO, CA

Position in VRTX

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$324,364

+$302,457 QoQ

Shares Held

653

+936.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,193

of 1,730 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 51% Shared 0% None 49%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $4,381,815 across 10 Biotechnology names. VRTX ranks #6 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCEL	Vericel Corp	26,219	$1,166,483
2	PCVX	Vaxcyte, Inc.	13,279	$771,908
3	JAZZ	Jazz Pharmaceuticals plc	2,447	$589,653
4	REGN	Regeneron Pharmaceuticals, Inc.	931	$580,515
5	RPRX	Royalty Pharma plc	6,991	$391,985
6	VRTX	Vertex Pharmaceuticals Inc / Ma This page	653	$324,364
7	INCY	Incyte Corp	2,148	$243,497
8	EXEL	Exelixis, Inc.	3,885	$211,382

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$324,364	653	+936.5%	Shares	Sole	2026-07-28
2023-09-30	$21,907	63	+1.6%	Shares	Sole	2023-11-15
2023-06-30	$21,818	62	-10.1%	Shares	Sole	2023-08-14
2023-03-31	$21,739	69	-95.8%	Shares	Sole	2023-05-16
2022-12-31	$479,374	1,660	-3.4%	Shares	Sole	2023-02-14
2022-09-30	$497,719	1,719	-23.2%	Shares	Sole	2022-11-14
2020-12-31	$528,928	2,238	-61.2%	Shares	Sole	2021-02-17
2020-09-30	$1,570,676	5,772	+13.3%	Shares	Sole	2020-11-16
2020-06-30	$1,479,129	5,095	-6.1%	Shares	Sole	2020-08-12
2020-03-31	$1,291,116	5,426	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.